431 related articles for article (PubMed ID: 10946021)
1. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.
Escolà-Gil JC; Julve J; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
J Lipid Res; 2000 Aug; 41(8):1328-38. PubMed ID: 10946021
[TBL] [Abstract][Full Text] [Related]
2. Increased production of very-low-density lipoproteins in transgenic mice overexpressing human apolipoprotein A-II and fed with a high-fat diet.
Julve J; Escolà-Gil JC; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
Biochim Biophys Acta; 2000 Nov; 1488(3):233-44. PubMed ID: 11082533
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate.
Ribas V; Palomer X; Roglans N; Rotllan N; Fievet C; Tailleux A; Julve J; Laguna JC; Blanco-Vaca F; Escolà-Gil JC
Biochim Biophys Acta; 2005 Dec; 1737(2-3):130-7. PubMed ID: 16226489
[TBL] [Abstract][Full Text] [Related]
4. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.
Brunzell JD; Albers JJ; Chait A; Grundy SM; Groszek E; McDonald GB
J Lipid Res; 1983 Feb; 24(2):147-55. PubMed ID: 6403642
[TBL] [Abstract][Full Text] [Related]
5. Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein.
Blanco-Vaca F; Escolà-Gil JC; Martín-Campos JM; Julve J
J Lipid Res; 2001 Nov; 42(11):1727-39. PubMed ID: 11714842
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.
Hunt SC; Wu LL; Hopkins PN; Stults BM; Kuida H; Ramirez ME; Lalouel JM; Williams RR
Arteriosclerosis; 1989; 9(3):335-44. PubMed ID: 2497719
[TBL] [Abstract][Full Text] [Related]
7. A mouse model with features of familial combined hyperlipidemia.
Masucci-Magoulas L; Goldberg IJ; Bisgaier CL; Serajuddin H; Francone OL; Breslow JL; Tall AR
Science; 1997 Jan; 275(5298):391-4. PubMed ID: 8994037
[TBL] [Abstract][Full Text] [Related]
8. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
9. A variation in the apolipoprotein C-III gene is associated with an increased number of circulating VLDL and IDL particles in familial combined hyperlipidemia.
Ribalta J; La Ville AE; Vallvé JC; Humphries S; Turner PR; Masana L
J Lipid Res; 1997 Jun; 38(6):1061-9. PubMed ID: 9215535
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins.
Huang Y; Liu XQ; Rall SC; Mahley RW
J Biol Chem; 1998 Jul; 273(28):17483-90. PubMed ID: 9651338
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
[TBL] [Abstract][Full Text] [Related]
13. Low density lipoprotein metabolism in familial combined hyperlipidemia. Mechanism of the multiple lipoprotein phenotypic expression.
Kissebah AH; Alfarsi S; Evans DJ
Arteriosclerosis; 1984; 4(6):614-24. PubMed ID: 6508636
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of apolipoprotein B in members of a family with accelerated atherosclerosis: influence of apolipoprotein E-3/E-2 pattern.
Haffner SM; Kushwaha RS; Hazzard WR
Metabolism; 1992 Mar; 41(3):241-5. PubMed ID: 1542261
[TBL] [Abstract][Full Text] [Related]
15. Effects of dietary fish oil on serum lipids and VLDL kinetics in hyperlipidemic apolipoprotein E*3-Leiden transgenic mice.
van Vlijmen BJ; Mensink RP; van 't Hof HB; Offermans RF; Hofker MH; Havekes LM
J Lipid Res; 1998 Jun; 39(6):1181-8. PubMed ID: 9643349
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of the lipoprotein structure in the St. Thomas' Mixed Hyperlipidaemic (SMHL) rabbit.
de Roos B; Caslake MJ; Milliner K; Benson GM; Suckling KE; Packard CJ
Atherosclerosis; 2005 Jul; 181(1):63-8. PubMed ID: 15939055
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of high density lipoprotein precursors from apolipoprotein B-containing lipoproteins in the presence of unesterified fatty acids and a source of apolipoprotein A-I.
Musliner TA; Long MD; Forte TM; Nichols AV; Gong EL; Blanche PJ; Krauss RM
J Lipid Res; 1991 Jun; 32(6):917-33. PubMed ID: 1940624
[TBL] [Abstract][Full Text] [Related]
19. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
20. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]